“Drug repurposing can potentially see a cheap, good, and powerful drug like aspirin prevent and even treat cancer effectively,” said Dr Toh Han Chong, deputy director of National Cancer Centre, Singapore. He and Dr. Chia are leading the first global clinical trial, named Ascolt, to see if aspirin can stop the recurrence of cancer after surgery.
If aspirin proves to be effective against recurrent cancer, it will change global clinical practice. According to Dr. Chia, everyone with stage 2 or 3 colorectal cancer will be put on it, and it will have an immediate impact, saving 10,000 lives each year at a very low cost.
There are now only a few drugs that can prevent high-risk stage 2 and stage 3 colon cancer from recurring after surgery, making Aspirin all the more vital in this field.